This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sucampo Pharmaceuticals Inc (SCMP)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 44.10M 52.02M 50.66M 49.24M
Receivables 20.25M 16.27M 17.45M 13.05M
Inventories 209.00K 0.00 0.00 0.00
Other Current Assets 673.00K 2.60M 3.06M 0.00
Total Current Assets 113.35M 92.91M 114.92M 134.54M
Property, Plant & Equipment, Gross 4.53M 4.51M 4.11M 4.03M
Accumulated Depreciation & Depletion 3.38M 2.97M 2.44M 2.00M
Property, Plant & Equipment, Net 1.16M 1.54M 1.67M 2.02M
Intangibles 6.44M 7.42M 8.36M 0.00
Other Non-Current Assets 14.81M 24.27M 30.53M 8.53M
Total Non-Current Assets 23.62M 34.88M 42.65M 14.73M
Liabilities & Shareholder Equity
Total Assets 136.97M 127.80M 157.57M 149.27M
Accounts Payable 7.61M 5.50M 6.98M 4.20M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.06M 1.15M 0.00 0.00
Total Current Liabilities 42.61M 40.07M 47.08M 38.92M
Long Term Debt 25.83M 33.72M 39.23M 44.44M
Deferred Income Taxes 2.07M 2.63M 23.02M 0.00
Other Non-Current Liabilities 8.32M 8.35M 9.65M 12.08M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 36.21M 44.70M 71.89M 56.52M
Total Liabilities 78.82M 84.77M 118.98M 95.44M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 58.15M 43.03M 38.59M 53.83M
Common Par 432.00K 420.00K 419.00K 418.00K
Additional Paid In Capital 72.11M 62.52M 59.96M 58.47M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -27.68M -34.10M -38.94M -21.63M
Treasury Stock -2.31M -1.98M -700.00K 0.00
Other Equity Adjustments 15.60M 16.17M 17.85M 16.57M
Total Capitalization 83.98M 76.75M 77.82M 98.27M
Total Equity 58.15M 43.03M 38.59M 53.83M
Total Liabilities & Stock Equity 136.97M 127.80M 157.57M 149.27M
Total Common Shares Outstanding 43.32M 41.96M 41.88M 41.85M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 524.79K 457.03K 186.99K 0.00
Basic Weighted Shares Outstanding 41.72M 41.66M 41.84M 41.85M
Diluted Weighted Shares Outstanding 42.54M 41.78M 41.84M 41.85M
Number of Employees 77 128 108 93
Number of Part-Time Employees 0 0 0 0
SCMP News

SCMP Sucampo Pharmaceuticals Inc

Analysts Ratings for SCMP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SCMP ANALYST REPORT

Brokerage Partners

SCMP Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs